The official blog of the Lung Institute.

Lung Institute Doctors Attend Mayo Clinic Seminar

15 May 2015
| Under Press | Posted by | 2 Comments
Mayo Clinic Pulmonary Fibrosis Seminar

2015 Multidisciplinary Update in Pulmonary and Critical Care Medicine

Tampa, FL (May 15, 2015) – The 2015 Multidisciplinary Update in Pulmonary and Critical Care Medicine proved to be a successful and informative event, held at the end of April in Scottsdale, AZ. The seminar included lectures, case studies, literature reviews and state-of-the-art updates regarding pulmonary health. It is intended for healthcare professionals in Pulmonology, Critical Care, Internal Medicine, Hospital Medicine, Thoracic Surgeons and other related fields. The event centers on comprehensive care for pulmonary disorders. A Lung Institute doctor attended the conference to stay informed on cutting edge technology in the field of pulmonary study.

While the Lung Institute specializes in stem cell therapy to treat those suffering from debilitating lung disease, the Lung Institute recognizes that it is imperative to stay up to date with the medical advancements in the industry in order to offer the most effective care to their patients. Lectures at the event were given by leaders in pulmonary and critical care medicine, pulmonary pathology and radiology. The comprehensive approach to pulmonary care provides event-goers with well rounded, cutting edge information in the field.

Some hot topics at the seminar included: acute respiratory distress syndrome (ARDS), new pulmonary hypertension treatment breakthroughs, updates in sepsis management, noninvasive ventilation strategies, current state of lung transplant research and more.

About the Lung Institute

At the Lung Institute, we are changing people’s lives across the nation through the innovative technology of regenerative medicine. We recognize the challenges of finding effective and sustainable treatment options for patients who might be suffering from debilitating lung diseases, and we are committed to providing patients a more effective way to address pulmonary conditions and improve quality of life. Our goal is to help patients breathe easier and bring life back within reach. For more information, visit our website at LungInstitute.com, like us on Facebook, follow us on Twitter or call us today at (800) 729-3065.


  1. Maren Auxier

    3 years ago

    Hi Colyne,

    Thanks for your comment. We do treat rheumatoid lung, however, everyone’s condition is unique. I would recommend calling one of our Patient Coordinators for a consultation to see if you qualify for treatment or if treatment may benefit you. Please call (855) 313-1149 to speak with one of our Patient Coordinators. Thanks!

  2. Colyne Gibbons

    3 years ago

    I have been diagnosed with rheumatoid lung, prescribed 10mgs of prednisone, and told I likely have from 6 to 12 months to live. No attempt to possibly addressing this condition has been considered, I believe because, I’m 79 years old. Why waste time and money on an otherwise healthy individual who is going to die anyway likely in 4 or 5 years of old age. Nothing would thrill me more than to thumb my nose at the Canadian doctors who have betrayed their profession of healing the sick for the expediency of their monthly government cheque.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.